Zomedica Has Launched Its Third Equine-focused Assay-insulin For Equine Plasma-For Truforma In-Clinic Biosensor Testing Platform
Zomedica Has Launched Its Third Equine-focused Assay-insulin For Equine Plasma-For Truforma In-Clinic Biosensor Testing Platform
zomedica已經推出了第三種針對馬匹血漿胰島素的檢測—用於Truforma診所生物傳感器測試平台
- Veterinarians test equine insulin levels when they suspect Equine Metabolic Syndrome (EMS) or other forms of insulin dysregulation, as frequently occurs with equine Cushing's disease, or Pituitary Pars Intermedia Dysfunction (PPID), with prevalence reported between 18-27% of ponies and horses. Left untreated, laminitis, which can lead to euthanasia, is a consequence of both EMS and PPID.
- The TRUFORMA Insulin assay offers quantitative detection of insulin levels in equine plasma, with results available in just 18 minutes. This rapid turnaround enables veterinarians to diagnose and monitor insulin dysregulation in horses quickly, eliminating the need for reference laboratory wait times and allowing for immediate treatment decisions. The assay is designed for both in-clinic and stall-side use, providing flexibility for various clinical settings. Importantly, Zomedica offers this advanced diagnostic capability with no capital outlay or monthly minimums from veterinary practices.
- 獸醫在懷疑馬匹代謝綜合症（EMS）或其他類型的胰島素失調時，會檢測馬匹的胰島素水平，這種情況常見於馬匹庫欣病或垂體中間部功能障礙（PPID），在小型馬和馬中的患病率報告爲18-27%。如果不加以治療，LAMINITIS（蹄葉炎）可能會導致安樂死，這是EMS和PPID的結果。
- TRUFORMA胰島素測定提供對馬匹血漿中胰島素水平的定量檢測，結果僅需18分鐘即可獲得。這一快速的檢測結果使獸醫能夠迅速診斷和監測馬匹的胰島素失調，消除了對參考實驗室等待時間的需求，並允許立即做出治療決定。該測定設計用於臨床和馬廄旁的使用，爲各種臨床環境提供靈活性。值得注意的是，zomedica提供這種愛文思控股的診斷能力，無需獸醫實踐的資本支出或月最低要求。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間